Iovance Biotherapeutics Inc (IOVA) USD0.000041666
1.35%- This stock can be held in a
Stocks and Shares ISASell:$5.75
Buy:$5.88
Change:
$0.17
(2.93%)
$0.17
(2.93%)Market closed | Prices delayed by at least 15 minutes
Sell:$5.75
Buy:$5.88
Change:$0.17
(2.93%)
$0.17
(2.93%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 14 January 2025 | Frederick G (Fred) VogtCEO | Sell Tax related | 9,955 | $5.89 | $58,634.95 | 221,116 |
| 14 January 2025 | Friedrich Graf FinckensteinChief Level Officer | Sell Tax related | 1,578 | $5.89 | $9,294.42 | 63,886 |
| 14 January 2025 | Igor P. BilinskyCOO | Sell Tax related | 1,578 | $5.89 | $9,294.42 | 58,774 |
| 16 December 2024 | Raj K PuriChief Level Officer | Sell Tax related | 3,759 | $7.84 | $29,470.56 | 155,412 |
| 2 December 2024 | Frederick G (Fred) VogtCEO | Sell Tax related | 4,426 | $9.07 | $40,143.82 | 210,236 |
| 2 December 2024 | Friedrich Graf FinckensteinChief Level Officer | Sell Tax related | 1,982 | $9.07 | $17,976.74 | 62,651 |
| 2 December 2024 | Igor P. BilinskyCOO | Sell Tax related | 1,784 | $9.07 | $16,180.88 | 57,539 |
| 12 November 2024 | Ryan D MaynardDirector | Sell Option/Award related | 50,000 | $10.06 | $503,000.00 | 7,500 |
| 14 October 2024 | Frederick G (Fred) VogtCEO | Sell Tax related | 8,851 | $9.77 | $86,474.27 | 204,245 |
| 14 October 2024 | Friedrich Graf FinckensteinChief Level Officer | Sell Tax related | 1,428 | $9.77 | $13,951.56 | 60,727 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 20 February 2024 | Wayne P RothbaumIndependent Director | Buy Regular purchase transaction | 5,000,000 | $9.15 | $45,750,000.00 | 28,067,333 |
| 20 February 2024 | Merrill A. (Tony) McPeakIndependent Director | Buy Regular purchase transaction | 250,000 | $9.15 | $2,287,500.00 | 320,150 |
| 12 November 2024 | Ryan D MaynardDirector | Sell Option/Award related | 50,000 | $10.06 | $503,000.00 | 7,500 |
| 20 February 2024 | Iain D DukesChairman of the Board | Buy Regular purchase transaction | 32,000 | $9.15 | $292,800.00 | 54,000 |
| 3 September 2024 | Frederick G (Fred) VogtCEO | Sell Tax related | 19,913 | $10.85 | $216,056.05 | 192,262 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.